PAPER Hiltunen H, Tan EC, Ilomäki J, Hilmer SN, Visvanathan R, Emery T, Robson L, Jones MJ, Hartikainen S, Bell JS
SEARCH RESULTS
270837 RESULTS
PAPER Khoury R, Rajamanickam J, Grossberg GT
An update on the safety of current therapies for Alzheimer's disease: focus on rivastigmine.
Ther Adv Drug Saf. 2018 Mar;9(3):171-178. Epub 2018 Jan 8 PubMed.PAPER Hillen JB, Soulsby N, Alderman C, Caughey GE
Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review.
Ther Adv Drug Saf. 2019;10:2042098619846993. Epub 2019 May 15 PubMed.PAPER Malone K, Hancox JC
QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine.
Ther Adv Drug Saf. 2020;11:2042098620942416. Epub 2020 Aug 17 PubMed.PAPER Antonelli MT, Cox JS, Saphirak C, Gurwitz JH, Singh S, Mazor KM
Motivating deprescribing conversations for patients with Alzheimer's disease and related dementias: a descriptive study.
Ther Adv Drug Saf. 2022;13:20420986221118143. Epub 2022 Aug 23 PubMed.PAPER Samaras K, Sachdev PS
Diabetes and the elderly brain: sweet memories?
Ther Adv Endocrinol Metab. 2012 Dec;3(6):189-96. PubMed.PAPER Shi X, Li L, Liu Z, Wang F, Huang H
Exploring the mechanism of metformin action in Alzheimer's disease and type 2 diabetes based on network pharmacology, molecular docking, and molecular dynamic simulation.
Ther Adv Endocrinol Metab. 2023;14:20420188231187493. Epub 2023 Sep 27 PubMed.PAPER Edmiston EA, Bej TA, Wilson B, Jump RL, Phillips JA
Donepezil-associated survival benefits among Alzheimer's disease patients are retained but not enhanced during COVID-19 infections.
Ther Adv Infect Dis. 2023;10:20499361231174289. Epub 2023 May 22 PubMed.PAPER Simpkins JW, Perez E, Wang X, Yang S, Wen Y, Singh M
The potential for estrogens in preventing Alzheimer's disease and vascular dementia.
Ther Adv Neurol Disord. 2009 Jan;2(1):31-49. PubMed.PAPER Lanctôt KL, Rajaram RD, Herrmann N
Therapy for Alzheimer's Disease: How Effective are Current Treatments?
Ther Adv Neurol Disord. 2009 May;2(3):163-80. PubMed.PAPER Kennelly SP, Lawlor BA, Kenny RA
Blood pressure and dementia- a comprehensive review.
Ther Adv Neurol Disord. 2009 Jul;2(4):241-60. PubMed.PAPER Greenberg BM, Frohman E
Optical coherence tomography as a potential readout in clinical trials.
Ther Adv Neurol Disord. 2010 May;3(3):153-60. PubMed.PAPER Wozniak MA, Itzhaki RF
Antiviral agents in Alzheimer's disease: hope for the future?
Ther Adv Neurol Disord. 2010 May;3(3):141-52. PubMed.PAPER Galimberti D, Scarpini E
Disease-modifying treatments for Alzheimer's disease.
Ther Adv Neurol Disord. 2011 Jul;4(4):203-16. PubMed.PAPER Srinivasan V, Cardinali DP, Srinivasan US, Kaur C, Brown GM, Spence DW, Hardeland R, Pandi-Perumal SR
Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.
Ther Adv Neurol Disord. 2011 Sep;4(5):297-317. PubMed.Current Filters
- TYPE: Paper x